Reuters Health Report

Click to View in Browser 04/9/2014 WHO joins clamor to make new hepatitis C pills affordable LONDON (Reuters) - The World Health Organization wants a "concerted effort" to drive down the cost of new hepatitis C drugs that offer a cure for the liver-destroying virus but are unaffordable for most infected people worldwide. FDA halts Halozyme's pancreatic cancer study (Reuters) - Halozyme Therapeutics Inc said the U.S. Food and Drug Administration ordered a halt on a study of its drug delivery system in pancreatic cancer patients, barely a week after the company voluntarily stopped the trial. India regulator examines Sun, Ranbaxy merger trading: source MUMBAI (Reuters) - India's market regulator will ask Ranbaxy Laboratories and Sun Pharmaceutical Industries for more information about their planned $3.2 billion merger and seek trading data from stock exchanges after shares in Ranbaxy surged in the run-up to the deal, a senior source at the regulator said on Wednesday. India's Sun Pharma plans gradual phase-out of Ranbaxy-branded drugs in U.S.: sources MUMBAI (Reuters) - India's Sun Pharmaceutical Industries Ltd plans to begin phasing out sales of generic drugs branded as Ranbaxy Laboratories Ltd products in the United States, after completing a $3.2 billion takeover of its loss-making rival by the year end, sources with direct knowledge of the matter said. Just because it's sweet and sticky doesn't mean it's 'honey': FDA WASHINGTON (Reuters) - Honey mixed with sugar might be sweet, but it is not "honey." Saudi records 11 cases of MERS virus in Jeddah ABU DHABI (Reuters) - Saudi Arabia said on Wednesday it had recorded 11 cases infected with the potentially deadly Middle East Respiratory Syndrome (MERS) virus in Jeddah, including hospital staff. U.S. has not determined legal authority to delay Obamacare mandate WASHINGTON (Reuters) - The U.S. administration has not determined whether it has legal authority to delay Obamacare's individual mandate, which requires most Americans to enroll in health insurance or pay a tax penalty, a senior Treasury official said on Tuesday. Japan drugmaker Takeda to fight $6 billion damages awarded by U.S. jury SAN FRANCISCO/TOKYO (Reuters) - Takeda Pharmaceutical Co Ltd said it would contest $6 billion in punitive damages imposed by a jury in the United States in a case that accused Japan's largest drugmaker of concealing cancer risks associated with its Actos diabetes drug. U.S. insurers still expect cuts in 2015 Medicare payments (Reuters) - U.S. health insurers said on Tuesday they still expected cuts in government reimbursements for privately managed Medicare health plans for the elderly next year even after the Obama administration rolled back the steepest reductions. Low-dose aspirin may prevent preeclampsia: panel NEW YORK (Reuters Health) - Pregnant women at a high risk for the potentially fatal complication preeclampsia should take low-dose aspirin after their first trimester, according to a government-backed panel. Related Video Communities clean up after storms in the South Mississippi tornado destroys buildings, injures seven The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend